|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0002 USD | +100.00% |
|
-.--% | -83.33% |
| 05-01 | Combined Hearing for Disclosure Statement and Plan Approved for Humanigen, Inc. | CI |
| 04-12 | Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. | CI |
Humanigen, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported revenue was USD 3.6 million compared to USD 0.312 million a year ago. Net loss was USD 236.65 million compared to USD 89.54 million a year ago.
Basic loss per share from continuing operations was USD 4.04 compared to USD 2.42 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -83.33% | 11.91K | |
| -2.29% | 89.38B | |
| -3.95% | 37.92B | |
| -13.07% | 32.04B | |
| +63.05% | 26.03B | |
| -22.14% | 14.14B | |
| -7.96% | 12.88B | |
| -9.33% | 11.77B | |
| -46.33% | 10.85B | |
| +5.77% | 8.92B |
HUMANIGEN, INC. 
